Racial and ethnic disparity in symptomatic breast cancer awareness despite a recent screen: The role of tumor biology and mammography facility characteristics

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1599-1606

  Mortel, Mylove ^a   Rauscher, Garth H ^a   Murphy, Anne Marie ^b   Hoskins, Kent ^a   Warnecke, Richard B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Metropolitan Chicago Breast Cancer Task Force   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DENSITY; CANCER SCREENING; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HEALTH CARE QUALITY; HISPANIC; HUMAN; INCOME; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS; ANCESTRY GROUP; AWARENESS; BREAST TUMOR; CANCER CENTER; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; ETHNOLOGY; FOLLOW UP; ILLINOIS; INCIDENCE; MIDDLE AGED; PROCEDURES; PROGNOSIS; PSYCHOLOGY; RETROSPECTIVE STUDY; URBAN POPULATION;

ADULT; AGED; AWARENESS; BREAST NEOPLASMS; CANCER CARE FACILITIES; CHICAGO; CONTINENTAL POPULATION GROUPS; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; URBAN POPULATION;

EID: 84942942222     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0305     Document Type: Article

References (43)

1. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, et al. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37, W237-42.
2. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92.
3. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: Analysis of randomized screening trials. J Natl Cancer Inst 2005;97:1195-203.
4. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;42:793-806.
5. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-56.
6. Richardson LC, Rim SH, Plescia M. Vital signs: breast cancer screening among women aged 50-74 years - United States, 2008. MMWR Morb Mortal Wkly Rep 2010;59:813-6.
7. Baquet CR, Mishra SI, Commiskey P, Ellison GL, DeShields M. Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2008;100:480-8.
8. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:52-62.
9. Ansell D, Grabler P, Whitman S, Ferrans C, Burgess-Bishop J, Murray LR, et al. A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Causes Control 2009;20:1681-8.
10. Allgood PC, Duffy SW, Kearins O, O'Sullivan E, Tappenden N, Wallis MG, et al. Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. Br J Cancer 2011;104:1680-5.
11. Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004;292:1064-73.
12. Redondo M, Funez R, Medina-Cano F, Rodrigo I, Acebal M, Tellez T, et al. Detection methods predict differences in biology and survival in breast cancer patients. BMC Cancer 2012;12:604.
13. Chiarelli AM, Edwards SA, Sheppard AJ, Mirea L, Chong N, Paszat L, et al. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69. Eur J Cancer Prev 2012;21:499-506.
14. Porter PL, El-Bastawissi AY, Mandelson MT, LinMG, Khalid N, Watney EA, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- And screen-detected cancers. JNatl Cancer Inst 1999;91:2020-8.
15. Rauscher GH, Allgood KL, Whitman S, Conant E. Disparities in screening mammography services by race/ethnicity and health insurance. J Womens Health 2012;21:154-60.
16. Rauscher GH, Khan JA, Berbaum ML, Conant EF. Potentially missed detection with screening mammography: does the quality of radiologist's interpretation vary by patient socioeconomic advantage/disadvantage? Ann Epidemiol 2013;23:210-4.
17. Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun EE, Warnecke RB. Misconceptions about breast lumps and delayedmedical presentation in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev 2010;19:640-7.
18. Dookeran K, Silva A, Warnecke RB, Rauscher GH. Race/ethnicity and disparities in mastectomy practice in the breast cancer care in Chicago Study. Ann Surg Oncol 2014;22:66-74.
19. Breast Imaging Center of Excellence - American College of Radiology [Internet]. [cited 2015 Mar 9]. Available from: http://www.acr.org/quality-safety/accreditation/bicoe.
20. Illinois Department of Healthcare and Family Services [Internet] [cited 2015 Mar 9]. Available from: http://www2.illinois.gov/hfs/MedicalProvider/MedicaidReimbursement/Pages/dsh.aspx.
21. Karlson KB, Holm A. Decomposing primary and secondary effects: A new decomposition method. Res Soc Stratification Mobility 2011;29:221-37.
22. Dawson SJ, Duffy SW, Blows FM, Driver KE, Provenzano E, LeQuesne J, et al. Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival. Br J Cancer 2009;101:1338-44.
23. Coates RJ, Uhler RJ, Brogan DJ, Gammon MD, Malone KE, Swanson CA, et al. Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States). Cancer Causes Control 2001;12:431-42.
24. Reeves MJ, Newcomb PA, Remington PL, Marcus PM. Determinants of breast cancer detection among Wisconsin (United States) women, 1988- 90. Cancer Causes Control 1995;6:103-11.
25. Thind A, Diamant A, Hoq L, Maly R. Method of detection of breast cancer in low-income women. J Womens Health 2009;18:1807-11.
26. Breen N, Yabroff KR, Meissner HI. What proportion of breast cancers are detected by mammography in the United States? Cancer Detect Prev 2007;31:220-4.
27. Roth MY, Elmore JG, Yi-Frazier JP, Reisch LM, Oster NV, Miglioretti DL. Self-detection remains a key method of breast cancer detection for U.S. women. J Womens Health 2011;20:1135-9.
28. Taplin SH, Rutter CM, Finder C, Mandelson MT, Houn F, White E. Screening mammography: clinical image quality and the risk of interval breast cancer. AJR Am J Roentgenol 2002;178:797-803.
29. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36.
30. Domingo L, Blanch J, Servitja S, Corominas JM, Murta-Nascimento C, Rueda A, et al. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers. Eur J Cancer Prev 2013;22:21-8.
31. Lowery JT, Byers T, Hokanson JE, Kittelson J, Lewin J, Risendal B, et al. Complementary approaches to assessing risk factors for interval breast cancer. Cancer Causes Control 2011;22:23-31.
32. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- And screen-detected cancers. J Natl Cancer Inst 2000;92:1081-7.
33. Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E. Breast density and outcome of mammography screening: A cohort study. Br J Cancer 2009;100:1205-8.
34. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209:511-8.
35. Miglioretti DL, Gard CC, Carney PA, Onega TL, Buist DS, Sickles EA, et al. When radiologists perform best: The learning curve in screening mammogram interpretation. Radiology 2009;253:632-40.
36. Smith-Bindman R, Chu P, Miglioretti DL, Quale C, Rosenberg RD, Cutter G, et al. Physician predictors ofmammographic accuracy. J Natl Cancer Inst 2005;97:358-67.
37. Esserman L, Cowley H, Eberle C, Kirkpatrick A, Chang S, Berbaum K, et al. Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst 2002;94:369-75.
38. Beam CA, Conant EF, Sickles EA. Association of volume and volumeindependent factors with accuracy in screening mammogram interpretation. J Natl Cancer Inst 2003;95:282-90.
39. Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, et al. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology 2009;253:641-51.
40. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748-57.
41. Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, et al. Mammography use among sociodemographically diverse women: The accuracy of self-report. Am J Public Health 1996;86:1016-21.
42. McPhee SJ, Nguyen TT, Shema SJ, Nguyen B, Somkin C, Vo P, et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med 2002;35:463-73.
43. Rauscher GH, Murphy AM, Orsi JM, Dupuy DM, Grabler PM, Weldon CB. Beyond MQSA: Measuring the quality of breast cancer screening programs. AJR Am J Roentgenol 2014;202:145-51.